Gilead price target raised to $130 from $120 at BMO Capital

BMO Capital raised the firm’s price target on Gilead (GILD) to $130 from $120 and keeps an Outperform rating on the shares. The company’s Q2 print provided a breath of fresh air with a clean beat and raise, coupled with bullish commentary on the ongoing launch of Yeztugo, the analyst tells investors in a research note. BMO adds that it remains positive on Gilead shares into the back half of the year with what should be a strong start to the launch of Yeztugo and iMMagine-1 data expected by 2025-end.